Last updated: November 16, 2024
Sponsor: Shandong University
Overall Status: Completed
Phase
N/A
Condition
Digestive System Neoplasms
Esophageal Disorders
Treatment
The diagnosis of Artificial Intelligence and endoscopist
Clinical Study ID
NCT04136236
2019SDU-QILU-66
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
aged between 18 and 80;
agree to give written informed consent;
Exclusion
Exclusion Criteria:
advanced esophageal squamous cell carcinoma or esophageal stenosis;
having no suspicious lesion of ESN found by WLE and IEE
known allergy to fluorescein sodium;
having coagulopathy or impaired renal function;
being pregnant or breastfeeding.
Study Design
Total Participants: 57
Treatment Group(s): 1
Primary Treatment: The diagnosis of Artificial Intelligence and endoscopist
Phase:
Study Start date:
August 01, 2019
Estimated Completion Date:
January 31, 2023
Connect with a study center
Qilu Hospital, Shandong University
Jinan, Shandong 250001
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.